Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Outline of Final Research Achievements |
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease that can affect almost any part of the body, and B cell play critical roles in pathogenesis of SLE through autoantibody production. In a mouse model of SLE, aberrant gene rearrangement and transcription were found at immunoglobulin heavy chain locus in immature B cells. In addition, we observed abnormal bone marrow B-cell development in mouse model of SLE. Moreover, we successfully generated a mouse model for B cell conditional deletion of differentiation regulatory factor. These findings open the possibility of using immunoglobulin rearrangement status as diagnostic tool for SLE.
|